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Non-coding microRNAs (miRNAs) have a fundamental role in gene regulation and expres-
sion in almost every multicellular organism. Only discovered in the last decade, miRNAs
are already known to play a leading role in many aspects of disease. In the vertebrate inner
ear, miRNAs are essential for controlling development and survival of hair cells. Moreover,
dysregulation of miRNAs has been implicated in sensorineural hearing impairment, as well
as in other ear diseases such as cholesteatomas, vestibular schwannomas, and otitismedia.
Due to the inaccessibility of the ear in humans, animal models have provided the optimal
tools to study miRNA expression and function, in particular mice and zebraﬁsh. A major
focus of current research has been to discover the targets of the miRNAs expressed in
the inner ear, in order to determine the regulatory pathways of the auditory and vestibular
systems. The potential for miRNAs manipulation in development of therapeutic tools for
hearing impairment is as yet unexplored, paving the way for future work in the ﬁeld.
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INTRODUCTION
Hearing loss (HL) is the most prominent neurosensory dis-
order in humans. Congenital deafness affects at least one in
500 newborns and more than half of these cases are hereditary
(National Institutes of Health, NIDCD)1. As HL is also age depen-
dent, more individuals can be affected at later stages of their
lives. The ear is a complex transducing organ, which consists of
both exterior and interior parts. Vibrations of the middle ear’s
bones mirroring incoming sounds are translated into vibration
of the basilar membrane, which in turn leads to mechanotrans-
duction at the organ of Corti in speciﬁed cells, the hair cells.
Mammalian auditory hair cells, surrounded by non-sensory sup-
porting cells, are the main functional components of the cochlea.
They are organized in three rows of outer hair cells (OHC)
and one row of inner hair cells (IHC). Their apical actin-based
microvilli are referred to as stereocilia. The mechanical stimu-
lus sensed by the stereocilia is converted into an action potential,
which in turn transfers the detected sound to the brain (Kelley,
2006). Speciﬁcally, coding of sound travels to the higher audi-
tory systems via the brainstem, where there are synapses in the
cochlear nuclei and the superior olivary complex (SOC), to the
inferior colliculus of the midbrain and ﬁnally to the auditory
cortex.
For many years, the conventional dogma in molecular biology
deﬁned themammalian genome as one containing protein-coding
genes and other repetitive and non-transcribed sequences. The
latter was deemed to be non-essential, unless directly involved in
RNA synthesis. The last decade has completely reversed this view
and the ﬁeld of non-coding RNAs (ncRNAs) has undergone a
dramatic metamorphosis as a portion of these RNAs, microRNAs
(miRNAs) are now recognized as having a vital role in gene expres-
sion and function. The ﬁrst recognized miRNAs were lin-7 and
let-7 in Caenorhabditis elegans (Lagos-Quintana et al., 2001), but
1http://www.nidcd.nih.gov/health/statistics/hearing.html
since then the number of these regulatory RNAs has grown to
30,424 mature miRNA sequences in 206 species (Kozomara and
Grifﬁths-Jones, 2011)2. miRNAs are the most studied and under-
stood forms of ncRNAs, and have been shown to fulﬁll regulatory
functions in many species, including the mammalian system.
miRNAs are small ∼23 nucleotide long RNA species. Pri-
miRNAs are transcribed togetherwith other formsof RNAbyRNA
polymerase II and processed through the Drosha–Dicer pathway
(Carthew and Sontheimer, 2009). While still in the nucleus, pri-
miRNAs are cleaved by Drosha and exported to the cytoplasm
via exportin 5. The product of the cleavage pre-miRNA hairpin
is composed of the main -5p and the complementary -3p (for-
mally star) strands that are connected by the stem loop. In the
cytoplasm, the pre-miRNA is cleaved by a second enzyme, Dicer,
to produce the mature miRNA. miRNAs possess a seed region
of 7 nt that determines its target speciﬁcity (Bartel, 2009). Upon
sequence complementarity, this region will bind to sequences at
the 3′ untranslated region (UTR) of target genes. In this fash-
ion,miRNAs inhibit targetmRNAs by translational repression and
mRNA destabilization (Guo et al., 2010) and regulate gene expres-
sion through the RNA interference (RNAi) pathway. Another
group of ncRNAs, long intervening noncoding RNAs (lincRNAs),
while more elusive in their classiﬁcation, are considered to have
expansive roles in gene regulation (Ulitsky and Bartel, 2013).
How have ncRNAs contributed to the study of the auditory and
vestibular systems? miRNAs were ﬁrst described in the zebraﬁsh
inner ear in 2005 (Wienholds et al., 2005), which heralded a num-
ber of studies in the mammalian inner ear worldwide. The study
of lincRNAs has not yet advanced at the same pace.
miRNAs IN THE INNER EAR
Since miRNAs have become an essential and fascinating aspect
of gene regulation in the inner ear, hundreds of miRNAs have
2http://www.mirbase.org
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been identiﬁed using microarrays (Weston et al., 2006; Friedman
et al., 2009; Wang et al., 2010a; Elkan-Miller et al., 2011; Zhang
et al., 2013). The speciﬁc expression of a fraction of these miRNAs
has been determined by in situ hybridization in the mouse inner
ear (Figures 1 and 2). There are still many inner ear-expressing
miRNAs waiting to be further characterized, both with regards to
expression, targets and mechanisms.
ThemiR-183 family is themost characterizedmiRNA cluster in
the inner ear. This conservedmiRNA triad, composed of miR-183,
miR-182, and miR-96, is transcribed in one polycistronic tran-
script. In both zebraﬁsh and the mouse, the triad co-expressed
in several neurosensory organs, including the ear, nose, and eye
(Wienholds et al., 2005; Weston et al., 2006; Karali et al., 2007). A
study demonstrating the role of themiR-183 family in zebraﬁsh by
reducing and increasing levels of miRNAs by morpholino (MO)
or miRNA injection, respectively, revealed that the miR-183 clus-
ter is crucial for inner ear hair cell and neuronal development
(Li et al., 2010). While the miRNAs overlap in their function,
given the similarity in their seed regions, they may have dif-
ferent targets, due to the differences in resulting phenotypes
following overexpression of each. In the ENU diminuendo mouse
with a miR-96 mutation (Lewis et al., 2009). the expression of
all three miRNAs remained intact, indicating that the mutation
did not disturb the biogenesis of the triad. The mutant mouse
showed rapidly progressive HL and hair cell abnormalities. In a
search for miR-96 targets, 12 were predicted by miRanda with
stringent ﬁltering and ﬁve were validated by luciferase assay anal-
ysis, Aqp5, Celsr2, Myrip, Odf2, and Ryk. Since the mutation
changes miR-96 seed region, the study suggests that a new seed
region was created, now binding to new targets, and therefore
both loss of normal targets and gain of novel targets could be
responsible for the phenotype. In a microarray comparing gene
expression between the wild type and the mutant diminuendo
mouse inner ears, 96 transcripts were signiﬁcantly affected. Five
genes weremarkedly down-regulated and strongly and speciﬁcally
expressed in hair cells: Slc26a5 (prestin), Ocm (oncomodulin),
Pitpnm1, Gﬁ1, and Ptprq. None of these genes has a miR-96
binding site, suggesting these are indirect downstream targets,
and their change in expression may be causing the diminuendo
phenotype.
Further studies on the diminuendo mouse found that miR-
96 is responsible for the maturation of the stereocilia bundle
of the inner and OHC (Kuhn et al., 2011). Moreover, the
synaptic morphology of the mutant mice remained immature,
suggesting that miR-96 is involved in cochlear auditory nerve
formation.
FIGURE 1 | Spatial expression patterns of miRNAs in the mouse
cochlea. The expression data is based on in situ hybridization experiments
of P0 mouse inner ear sections, except for miR-194 at E16.5, miR-140 at P1
and miR-124a and -100a at P5. miR-200b is ubiquitously expressed in all
epithelial cells in the inner ear, both in the cochlea and vestibule at P0
(Weston et al., 2006; Friedman et al., 2009; Sacheli et al., 2009; Soukup
et al., 2009; Wang et al., 2010a,b; Elkan-Miller et al., 2011; Hertzano et al.,
2011; Yan et al., 2012).
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FIGURE 2 | Spatial expression patterns of miRNAs in the postnatal
mouse vestibule. The expression data is based on in situ
hybridization experiments of P0 mouse inner ear sections, except for
miR-140 at P1, and miR-124a and -100a at P5 (Weston et al., 2006;
Friedman et al., 2009; Wang et al., 2010a; Elkan-Miller et al., 2011; Yan
et al., 2012).
Identiﬁcation of targets is a key ingredient for deciphering the
function of an miRNA. Several studies deﬁned targets for mem-
bers of the miR-183 triad. In a study on cells derived from mouse
otocysts, miR-182 promoted differentiation of these cells to a hair
cell-like fate (Wang et al., 2012). Moreover, the transcription factor
Tbx1 was found to be a target of miR-182. Tbx1 is a critical gene
in DiGeorge syndrome, with the phenotype of patients includ-
ing ear and hearing abnormalities. Tbx1 mouse mutants exhibit
severe inner ear defects. Therefore the tightly regulated transcrip-
tional regulation of Tbx1 in themammalian earmay be inﬂuenced
in part by miR-182, providing a function in crucial inner ear
developmental pathways.
Clic5, a chloride intracellular channel that is associated with
stereocilia in the inner ear, was identiﬁed as a target of bothmiR-96
and miR-182 (Gu et al., 2013). Clic5-mutant mice stereocilia bear
a resemblance to the morphology of the diminuendo ENU mouse
described above, leading to an investigation of its connection to
this triad. Clic5 contains a miR-96/182 binding site and its activity
was conﬁrmed by a luciferase assay. Liposome transfection of these
miRNAs into auditory-cell derived HEI-OC1 led to a reduction of
Clic5 at both mRNA and protein levels.
The triad clearly plays an important role in other sensory
systems. Inactivation of the three miRNAs in the mouse led to
multiple sensory defects, with an emphasis on the loss of this triad
in the retina (Lumayag et al., 2013). Not only did the mice have
progressive retinal degeneration and photoreceptor defects, but
there were signiﬁcant changes in overall retinal gene expression, as
revealed by proﬁling of microarrays.
Another well-characterized and highly expressing miRNA in
the brain, miR-124 (Lagos-Quintana et al., 2002), appears to have
an essential role in the inner ear. miR-124 is expressed in the
inner ear in neuronal cells in the spiral and vestibular ganglia
(Weston et al., 2006). In a study on the differential expression
of miRNAs between cochlear and vestibular sensory epithelia,
miR-124 was one of the most highly differentially expressed
miRNAs, with eightfold higher expression in the cochlea. This
suggests a speciﬁc role and targets for miR-124 in the cochlear
neurons of the inner ear (Elkan-Miller et al., 2011). A recent
study, searching for miRNAs that are involved in age-related hear-
ing loss (ARHL; see miRNAs in ARHL), compared differentially
expressed miRNAs in sensory epithelia of two mouse strains,
C57BL/6J and CBA/J, at several ages. miR-124 was one of four
miRNAs that were signiﬁcantly down regulated in both mouse
strains at the age of 9 months, compared to postnatal day (P)21
(Zhang et al., 2013). While more information regarding the tar-
gets of miR-124 to elucidate its role in the inner ear is required,
this miRNA should clearly have signiﬁcant inﬂuence on gene
regulation.
LOSS OF DICER IN THE INNER EAR
Dicer is a ribonuclease RNase III-like enzyme that is localized
in the nucleus and functions to process double-stranded RNA
(dsRNA).Dicer products then exit to the cytoplasmand are further
processed intomaturemiRNAs. Dicer ablation is lethal in zebraﬁsh
(Wienholds et al., 2005) and produces no viable embryos in mice
(Bernstein et al., 2003).
Dicer has been exploited to study miRNA function in the inner
ear. Several conditional knock out (CKO) models have been gen-
erated. The ﬁrst ear-speciﬁc Dicer1 CKO was generated using
Pax2::Cre for speciﬁc expression in regionswhere Pax2 is expressed
(Soukup et al., 2009). Dicer1 was ablated in the inner ear, kidneys
and midbrain, resulting in embryonic lethal mice. The CKO mice
showed signiﬁcant loss of most inner ear structures by embryonic
day (E)17.5. Although there was initial and normal formation and
growth of neurons, the nerves of the CKO animals were rapidly
lost after the decay in miRNA expression in the afferent neurons.
The ﬁrst viable mice were the Pou4f3::Cre-Dicer CKO mice,
using Dicer1 to remove miRNAs from hair cells (Friedman et al.,
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2009). Pou4f3 was used to express Dicer1 speciﬁcally in these
cells. The hair cells developed normally, but were degenerated
by postnatal day 38. Those that survived at this stage had an aber-
rant morphology and were presumably dysfunctional. This was
conﬁrmed by auditory brainstem response (ABR) testing, which
indicated that these mice were deaf. In addition, they showed
moderate vestibular dysfunction. Scanning electron microscopy
(SEM) demonstrated that the stereocilia of the auditory hair cells
were either missing or fused.
Foxg1 was used for site-speciﬁc expression to generate
Foxg1::Cre-Dicer CKO mice (Kersigo et al., 2011). Overall, these
mice had a reduction in anterodorsal regions of the skull, leading
to craniofacial abnormalities. As for the ear, it began to develop
abnormally aroundE12.5,with a signiﬁcant reduction in the size of
the ear by E14.5 and in the size of the otocyst by E18.5. This change
was concomitant with a reduction in the ossiﬁcation of the ear and
a smaller tympanic ring. miRNA-124 was found to be speciﬁcally
reduced prior to loss of the neurosensory portions, suggesting this
miRNA is required for normal neuronal development.
Another hair-cell speciﬁc CKO was generated using the gene
responsible for hair cell agenesis, Atoh1, to create Atoh1::Cre-
Dicer mice (Weston et al., 2011). Ablation of miRNAs in the hair
cells resulted in a progressive loss of OHCs from the base to the
apex, with OHCs being more prone to damage as compared to the
IHCs. The gradient in the rigorousness of hair cell loss hints that
there is also a gradient in the expression pattern of miRNAs along
the cochlea.
To study the role of Dicer and subsequent loss of miRNAs in
the central auditory pathway, Erg2::Cre-Dicer mice were created
(Rosengauer et al., 2012). Work on this CKO demonstrated that
Dicer is indispensable for the formation of the cochlear nucleus
complex (CNC) and the SOC. In the same study, an additional
CKO mouse, Atoh7::Cre-Dicer, was used to dissect later stages
of CNC formation. The CNC was comparable to the wild-type
mouse, suggesting that Dicer is not crucial for the formation of
these structures during late embryonic stages.
It is important to note that when drawing conclusions about
Dicer1 function at different stages of development, the tissue-
speciﬁc ablation is gradual and is speciﬁc to the Cre promoter
used. Therefore residual Dicer1 expression may exist, leading to a
less severe phenotype than expected with removal of this essen-
tial enzyme. Furthermore, there is no speciﬁcity with respect to
miRNAs and rather provide an “all or nothing effect.” For spe-
ciﬁc miRNAs, the approach taken to examine loss of miR-182 in
the retina is a relevant approach (Jin et al., 2009), though not yet
exploited in the inner ear.
IDENTIFICATION OF miRNA-PROTEIN TARGET PAIRS
Identifying novel or known miRNAs that are involved in spe-
ciﬁc processes in the inner ear and in the auditory pathways is
the relatively easy part of miRNA research. However, discern-
ing the molecular mechanisms, or moreover, the direct targets, is
considerably more tedious and challenging. This point is exem-
pliﬁed by the number of miRNAs that have been identiﬁed
versus the number of validated miRNA targets in the inner ear
(Table 1). Potential targets of any miRNA can be predicted via
TargetScan (Lewis et al., 2005), MicroCosm (formally MirBase;
Kozomara and Grifﬁths-Jones, 2011) and similar prediction pro-
grams. These algorithms ﬁnd a match between the 7-nucleotide
seed region of the miRNA and the 3′UTR target mRNAs. It is
important to note that this method is based on bioinformatics and
relies on sequence similarities between themiRNA and themRNA.
TargetScan and analogous programs cannot eliminate potential
targets on the basis of tissue speciﬁcity.
After the initial bioinformatic analyzes, each miRNA/gene tar-
get must be validated by experimental techniques. There are
several approaches for this validation. The most commonly used
in vitro technique is the luciferase assay. This quantitative assay
system was developed originally to assess promoter strength. In
the miRNA ﬁeld this technique is used to study whether there is a
direct interaction of a miRNA and a 3′UTR of a potential target
gene. Typically themiRNA is cloned into one vector and a 3′UTR is
cloned in-frame with luciferase. If the gene is a “true” target, there
will be no bioluminescence. If themiRNA cannot interact with the
3′UTR, luciferase will be produced continuously. If a direct inter-
action between the miRNA and gene target is found, one must
show that the mutation in the seed region of the miRNA can abol-
ish the binding. To demonstrate that miR-182 is a direct target
of Sox2, a luciferase assay was performed both with a luciferase
reporter vector with the 3′UTR of Sox2 and a mutated version
of the 3′UTR at the seed region of miR-182 (Weston et al., 2011).
The mutated 3′UTR could not bind miR-182 and the decrease in
luciferase activity that was observed in the wild-type construct was
lost.
To demonstrate an interaction in a more “in vivo” approach,
anti-miRNAs are used. These short oligonucleotides are used to
transfect either cell lines or cochlear cultures, and quench the
endogenous miRNAs. The outcome of the antagonism is then
probed either at the mRNA level, using qRT-PCR, or at the pro-
tein level, using western blot analysis, of the gene target. After
conﬁrming direct binding between miR-182 and the Tbx1 3′UTR
by luciferase assay, degradation of the target on anmRNA level was
tested (Wang et al., 2012). Isolated IHC infected with rA-miR-182
and transfected miR-182 inhibitor were collected and harvested
to explore Tbx1 transcription. In the presence of miR-182, the
mRNA levels of Tbx1 were restored as compared to infected cells,
suggesting target inhibition. Checking the expression level of the
predicted target gene by western blot can also provide evidence for
miRNA-gene target interaction. Skin samples from cholesteatoma
patients and control individuals were analyzed for protein levels of
the putative miR-21 targets, PTEN, and PCDC4 (Friedland et al.,
2009). In 75% of the cases, there was a substantial reduction in
the levels of both proteins, validating the predicted targets of the
miRNA.
Target recognition may be compromised as a result of a muta-
tion, as was suggested for some of the human miR-96 mutations
(Mencia et al., 2009). Given a change in the nucleotides that deﬁne
the speciﬁcity of the miRNA, the miRNA might lose its ability to
regulate its original targets. This hypothesis was examined with
the human miRNA mutations. As two different mutations in the
seed region of MIR-96, it was appealing to consider whether there
are any new acquired targets. However, they could not detect any
targets that are regulated by the “new” seed region of either of the
two mutations.
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Table 1 |Validation of miRNA-gene targets found in the inner ear.
miRNA Gene target Experimental system used Reference
miR-183 TAO kinase 1 (Taok1)
Early growth response 1 (Egr1)
Insulin receptor substrate 1 (Irs1)
Rat cochlear organotypic cultures transfected
with antisense morpholinos.
Patel et al. (2013)
miR-182 SRY-box containing transcription factor (Sox2) In situ hybridization; luciferase assay in HEK293
cells
Weston et al. (2011)
miR-182 T-box 1 (Tbx1) Luciferase assay in COS1 cells; overexpression
of miR in cultured otic progenitor/stem cells.
Wang et al. (2012)
miR-96, miR-182 Chloride intracellular channel 5 (Clic5) Co-expression in mouse auditory HEI-OC1 cells;
luciferase assay in A549 cells; down-regulation
of target.
Gu et al. (2013)
miR-15a Solute carrier family 12 (sodium/potassium/chloride
transporters), member 2 (Slc12a2), Claudin (Cldn12)
Brain-derived neurotrophic factor (Bdnf)
In situ hybridization; luciferase assay in
HEK-293T cells.
Friedman et al. (2009)
miR-21 Phosphatase and tensin homolog (Pten) Down-regulation of target in cholesteatoma;
inhibition of miR.
Friedland et al. (2009),
Ciofﬁ et al. (2010)
miR-21 Programmed cell death 4 (Pdcd4) Western blot on cholesteatoma skin samples. Friedland et al. (2009)
miR-135b PC4 and SFRS1 interacting protein 1 (Psip1-p75) Luciferase assay and qRT-PCR on Cal51, breast
carcinoma, cells; inhibition of miR.
Elkan-Miller et al. (2011)
miR-200b Zinc ﬁnger E-Box binding homeobox 1 (Zeb1) Global gene expression analysis;
complementary patterns of expression validated
with in situ and immunohistochemistry
Hertzano et al. (2011)
MECHANISMS OF miRNA FUNCTION IN THE INNER EAR
Roles of miRNAs in the inner ear can be also studied through iden-
tiﬁcation of the overall intracellular pathways they are involved in.
As such, proof of principle methods to check the global effect
of the miRNA regulation using cellular assays, such as BrdU
incorporation for proliferation or nuclear condensation by pro-
pidium iodide and caspase 3 activation for apoptosis. The latter
was incorporated into a study to induce HL by means of expo-
sure to high frequency noise and aimed to assess the amount
of apoptotic hair cells (Patel et al., 2013). From these experi-
ments they learned that the amount of nuclear condensation,
an explicit sign of apoptosis, probed with the DNA intercalating
agent propidium iodide is comparable following noise exposure.
In a different study, set to investigate whether certain miRNAs can
promote proliferation of cells in the chick inner ear, basilar papilla
were cultured in the presence of BrdU a cell cycle marker that is
incorporated instead of thymidine during DNA synthesis (Frucht
et al., 2010). Cells were transfected with pre-miRNA181a or anti-
miR181a and imaged. A signiﬁcant number of new hair cells could
be observed, providing a role of miR-181a in the pro-proliferative
process.
Possibly the most direct method to study the involvement
of miRNAs in inner ear mechanisms is in a model animal.
Both zebraﬁsh and mice are used to generate knock-out model
systems of a single miRNA or miRNA family. Studying these
models provides a global indication of phenotypes and can pro-
vide information on the targets and the signaling networks in
which these miRNAs are involved. More speciﬁcally, to study
the roles of miR-15a-1 and -18a in zebraﬁsh development,
antisense-oligonucleotide MOs were injected into zebraﬁsh 48 h
post-fertilization (Friedman et al., 2009). Bothmorphants showed
a reduction in hair cell number and different abnormalities in
inner ear structure, indicating that the two miRNAs act in parallel
but different pathways. Additional models may be obtained from
a resource of miRNA reporter and conditional knockout mouse
lines (Park et al., 2012).
EAR-RELATED PATHOLOGIES AND miRNAs
While not prevalent, a number of mutations inmiRNAs have been
associated with human HL. The ﬁrst mutations found were in
two unrelated Spanish families (Mencia et al., 2009). This dis-
covery provided strong evidence that two different mutations
in the seed region of MIR-96, +13 G>A, and +14 C>A, are
sufﬁcient to lead to dysregulation of the miRNA, with the end
result of progressive HL. An additional mutation was found in
MIR-96 in an Italian family during a screening for miRNA muta-
tions in 882 patients with NSHL (Solda et al., 2012). A mutation
in the seed region of miR-96-3p, +57 T>C, is associated with
HL in this family with progressive HL. The +57 T>C muta-
tion is predicted to lead to alteration of the secondary structure
of the pre-miR-96 hairpin. There was considerable reduction
in the expression of both miR-96-5p and -3p. The 5p of a
miRNA, together with its complementary strand 3pmiRNA, form
the pre-miRNA, which is then cleaved by Dicer. While miR-96
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transcripts were shown to be reduced in the +13 G < A miR-96
mutation (Mencia et al., 2009), but there was no change in miR-
3p, suggesting that the biogenesis of the pre-miRNA is normal.
While the mutated miR-96 is degraded, the mechanism is still
unknown.
In an effort to determinewhether themiRNA-183 cluster is fur-
ther involved in deafness, predicted target genes of the miR-183
miRNA,expressed in the inner ear,were screened in 150Americans
with autosomal dominant NSHL and 576 Iranians with autoso-
mal recessive NSHL (Hildebrand et al., 2010). A miRNA binding
site was predicted in the 3′UTR of radixin, a gene associated
with DFNB24 deafness. A variant was found in an Iranian family,
c.*95C>A, predicted to alter the binding site of miR-96/182 and
create a new miRNA binding site for miR-507 and -557. However,
during the validation process, no correlation was found between
either of themiRNAs and radixin. It appears thatmutations affect-
ing gene regulation of the miR-183 family are not typical causes
of a deafness phenotype.
miRNAs IN AGE-RELATED HEARING LOSS
While hearing impairment does not spare any population, the
aging population is hardest hit with this sensory loss. In the aging
population, 43% of individuals over the age of 65–75 have a HL
(National Academy on anAging Society)3. ARHL has both genetic
and environmental contributions. There is growing evidence that
miRNAs are involved in cell senescence, death and aging (Inukai
and Slack, 2013). To investigate whether miRNAs are involved in
regulation of ARHL and the processes leading to it, sensory epithe-
lia were dissected from two mouse strains at several ages, ranging
from 21 days after birth (P21) to 16 months (Zhang et al., 2013).
They hybridized the isolated RNA from each group on aGeneChip
microarray, probing for all known miRNA genes, and differential
expression of miRNAs was examined. In both strains, more miR-
NAs were downregulated from P21 to 9 or 16 month. Moreover,
there were a fewmiRNAs that were differentially expressed in each
one of the strains. The data veriﬁed that two miRNAs, miR-29a
and -34a, which have been implicated in apoptotic pathways, are
up-regulated and the twomiRNAs,miR-181 and -183, which have
been shown to have roles in proliferation and differentiation, are
down-regulated
While it is believed that a major cause of ARHL is the death
of hair cells, other age-related changes in the central auditory
pathways cannot be ruled out. It would therefore be useful to
examine the miRNA expression proﬁle in the SOC of aged mice
as well. In addition, with the aid of RNA-Seq techniques that have
become relatively common and less expensive, it is anticipated that
additional miRNAs will be found to play a role in ARHL using this
technology.
miRNAs IN THE MIDDLE EAR
Otitis media (OM) is the most common cause of HL in chil-
dren. OM is an inﬂammatory disease of the middle ear mucosa
(Lieberthal et al., 2013). While OM is predicted to be multi-
factorial, with bacterial infections as a contributing factor, its
3http://www.agingsociety.org/agingsociety/
etiology is largely unknown. The cell wall of gram-negative bacte-
ria is partly composed of lipopolysaccharides (LPS), which upon
interaction with the host, induce inﬂammation. Human mid-
dle ear epithelial cells (HMEECs), treated with LPS to trigger
inﬂammation, were used to study miRNAs that are differentially
expressed in this model system of OM (Song et al., 2011). A
gene expression analysis using microarrays led to the identiﬁca-
tion of 15 differentially expressed miRNAs in HMEECs treated
with LPS versus controls, ﬁve of which were upregulated and 10
were downregulated. mRNAs that are predicted to be targeted
by the upregulated miRNAs are involved in developmental pro-
cesses, response to biotic stimuli, acute inﬂammatory responses,
and regulation of cell growth, while the downregulated miR-
NAs are involved in developmental processes, cell differentiation,
endocytosis, cell communication, the NFkB cascade, complement
activation, innate immune response and cell adhesion. This is the
ﬁrst study to implicate miRNA regulation in OM.
miRNAs AND APOPTOSIS IN THE INNER EAR
Reactive oxygen species (ROS) are important intercellularmessen-
gers; however,when in excess, these species underlie processes such
as cell death and apoptosis by modulating the expression of many
genes (Circu and Aw, 2010). ROS have shown to be involved in
HL and speciﬁcally hair cell death (Kopke et al., 1999). Moreover,
they have been found in human inner ear perilymph derived from
patients with sensorineural HL (Ciorba et al., 2010). To explore
whether miRNAs are involved in ROS production in the ear, an
in vitro cellular model system was used. Tert-butyl hydroperoxide
(t-BHP) was used to promote generation of ROS inHEI-OC1 cells
derived from the organ of Corti (Wang et al., 2010b). The miRNA
expression proﬁle was determined for the t-BHP treated cells; 35
miRNAs were found to be upregulated, while 40 miRNAs were
downregulated. The treatment also modulated the expression of
manymRNAs, andmost relevant, changes inmiRNAswere associ-
ated with changes in mRNA expression of their predicted targets.
Speciﬁc examples of predicted miRNA-target pairs were IGF-1,
PIK3R1, and PTPN11, which were downregulated, with upregula-
tion of miR-29a,miR-17, andmiR-200c, respectively. These results
suggest that as a result of oxidative stress, the IGF-1 mediated sig-
naling was altered due to increased transcription of miRNAs in
this ROS model.
Antibiotic-induced HL is a major factor in ototoxicity. The
potential link between aminoglycoside toxicity and miRNA reg-
ulation and its effect on the inner ear was examined (Yu et al.,
2010). Kanamycin ototoxicity was induced in mice by subcuta-
neous injection and inner ears were analyzed. In response to the
treatment, themice exhibited a reducedABR response,whichdete-
riorated as a function of time. Cell death, evaluated by the TUNEL
assay, was increased in particular in the stria vascularis, supporting
cells and spiral ganglion cells. Due to their previously known role
in apoptosis, levels of the miR-34 family were examined in RNA
extracted fromcochleae of treatedmice by qRT-PCRanalysis. Both
miR-34a and miR-34c were signiﬁcantly elevated, as compared to
untreated controls. This data suggested that apoptosis in the inner
ear, followed by hearing damage in this model previously linked
to programmed cell death, is partly mediated by members of the
miR-34 family.
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miRNAs and REGENERATION IN THE INNER EAR
An early study in miRNAs and regeneration appeared soon after
the ﬁrst report of miRNAs in the mammalian inner ear (Tsonis
et al., 2007). The adult newt has the ability to regenerate body
parts, including the cells of the inner ear, by transdifferentiation
of terminally differentiate cells. In an effort to identify potential
changes in gene expression during this process, miRNA proﬁles
were examined during hair cell (and eye lens) regeneration. The
level of expression of let-7 miRNAs were found to be signiﬁcantly
reduced.While there have been several studies on lens regeneration
andmiRNAs since then, no additional studies on the ear have been
reported.
The avian auditory sensory epithelium, the basilar papilla, is
different from the mammalian sensory epithelium not only in its
structural organization, but also in its ability to regenerate fol-
lowing hair cell loss. As in the mammalian cochlea, in the basilar
papilla, both hair cells and supporting cells can be found. Upon
injury of any kind, such as noise or ototoxicity, there are new hair
cells produced from de-differentiation of supporting cells (Balak
et al., 1990). Supporting cells of birds that were exposed to acute
noise will re-enter cell cycle and within 4–5 days of trauma, new
hair cells couldbe found in the basilar papilla (Stone andCotanche,
2007).
To elucidate the role of miRNAs in the intracellular sig-
naling pathways of chick hair cell regeneration, forskolin, a
compound known to induce proliferation of supporting cells
to hair cells, was applied on basilar papilla cultures (Frucht
et al., 2010). The miRNA expression proﬁle was evaluated using
microarray analysis. miR-181a, which was greatly enriched in
the proliferating basilar papilla and as it had previously been
identiﬁed to have a role in promoting proliferation in a human
leukemia cell line, was selected as a hair cell proliferation candi-
date. Overexpression of miRNA-181a was indeed able to stimulate
proliferation within the basilar papilla, with new cells label-
ing with the hair cell marker myosin VI. A subsequent study
further explored miR-181a involvement in the pro-proliferative
processes in chickens (Frucht et al., 2011). To this end, the hair
cells of the basilar papilla were destroyed using streptomycin.
Down-regulation of this miRNA inhibited proliferation during
regeneration, rather than preventing hair cell death, providing not
only its mechanism in the process, but a promising candidate for
regeneration.
FUTURE OF miRNAs IN THE INNER EAR
High-throughput sequencing for RNA, dubbed RNA-seq, has
facilitated the study of miRNAs dramatically (Oshlack et al., 2010).
RNA-seq is being used to evaluate miRNA expression with a com-
parison of multiple sets of conditions. The large datasets obtained
can be narrowed down to a smaller set of miRNAs to be evaluated
in their role in regulation and gene expression. While RNA-seq
has been used in multiple ﬁelds to identify and characterize miR-
NAs, this technology has still not been exploited in the inner ear
ﬁeld.
The ﬁeld on ncRNAs in the mammalian inner ear is still
very much in development. While there has been tremendous
progress in the last decade, there are areas that are still in
their infancy. One such area is that of lincRNAs. lincRNAs are
relatively long stretches of RNA larger than 200nt (Ponting et al.,
2009). They were identiﬁed relying on knowledge from protein-
coding transcripts. Both coding and non-coding transcripts
have particular chromatin signatures consisting of H3K4me3
and H3K36me3. By identifying K4–K36 domains that lay out-
side known protein-coding loci, lincRNAs could be methodically
identiﬁed (Guttman et al., 2009). Unlike miRNAs, lincRNAs
have no shared structural characteristics; their biogenesis and
processing is unique, as well as their mode of action. There-
fore it is not straightforward to identify and study them. An
additional factor that hampers the research in the ﬁeld of
these new species is that lincRNAs are extremely cell- and
tissue-speciﬁc, making their discovery particular to each sys-
tem. Although there is some evolutionary conservation between
species, it is much less prominent than the one observed in
coding RNA transcripts, adding to the complexity of their
identiﬁcation. As opposed to miRNAs, the biological func-
tions of lincRNAs are largely unknown. Moreover, some of
the already described roles of the lincRNA are variable and
are not necessarily mutually exclusive (Da Sacco et al., 2012).
lincRNAs have been found to act as gene activators, gene sup-
pressors, cis and trans gene expression regulators, and chromatin
modiﬁcators.
LincRNAs have been shown to play a critical role in the devel-
opment and regulation of the sensory systems. As for the long
ncRNA species, lincRNAs have been found expressed in the
mouse retina (Mustaﬁ et al., 2013) and suggested to be associ-
ated with retinal and visual maintenance in mammals. Another
study showed that the taurine upregulated gene 1 (Tug1) lin-
cRNA is required for differentiation of the murine retina acting
via regulation of the cell cycle (Young et al., 2005). Two stud-
ies have reported lincRNAs in the inner ear. MEG3, a lincRNA
implicated in leukemia (Heuston et al., 2011), was examined fol-
lowing microarray detection experiment of enriched transcripts
in a mouse inner ear library (Manji et al., 2006). Following detec-
tion of its expression in the developing otocyst, spiral ganglion,
stria vascularis, Reissner’s membrane, and greater epithelial ridge
(GER), as well as hair and supporting cells, MEG3 was hypoth-
esized to play a role in pattern speciﬁcation and differentiation
during otocyst development andmaintenance terminally differen-
tiated cochlear cells. Rubie was identiﬁed as an inner-ear speciﬁc
lincRNA upstream of the Bmp4 gene (Roberts et al., 2012). Rubie
was predicted to be the gene mutated in epistatic circler (Ecl)
mice, contributing to its vestibular phenotype. There is clearly
room for a comprehensive investigation of lincRNAs in the inner
ear.
One of the most exciting developments in the ﬁeld has been
the generation of a novel in vitro model system for the inner
ear (Koehler et al., 2013). Mouse embryonic stem cells (ESC)
were differentiated in a step-wise manner into a 3D culture of
vestibular sensory epithelia. These cells showed characteristics of
innate hair cells; they were able to take up FM1-43 dye and exhib-
ited voltage-dependent currents. Moreover, ribbon synapses were
formed between the hair cells and neighboring neurons in the
3D culture. These cells may serve as a substrate for investigating
additional aspects of RNA regulation and lead to identiﬁcation of
additional RNA species in the inner ear.
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CONCLUSION
miRNAs are being developed as therapeutics for breast cancer
(Piva et al., 2013), rheumatic diseases (Pers and Jorgensen, 2013),
and hepatitis C virus infection (Lindow and Kauppinen, 2012;
Janssen et al., 2013), which are already involved in Phase 2 clini-
cal trials. The major limitations in miRNA research in the inner
ear are the lack of robust cell lines and the inability to gain access
to human tissue in an efﬁcient manner. Nevertheless, the identi-
ﬁcation of hundreds of miRNAs in the auditory system and the
elucidation of the function of many of thesemiRNAs and their tar-
gets holds promise for their use in therapeutics one day. A deeper
understanding of the regulatory elements involved in the diseased
state of the ear, including hearing impairment, cholesteatoma,
OM, and vestibular schwannomas can be reached, with miRNAs
serving as a potential source of regeneration therapies and rel-
evant pharmaceutical studies. The ability to generate stem cells
may open up further avenues for RNA regulation studies.
ACKNOWLEDGMENTS
Research in the Avraham laboratory is supported by the Israel Sci-
ence Foundation 1320/11, National Institutes of Health (NIDCD)
R01DC011835, I-CORE Gene Regulation in Complex Human
Disease Center No. 41/11, Human Frontier Science Program
RGP0012/2012, and Ministry of Immigrant Absorption (Kathy
Ushakov).
REFERENCES
Balak, K. J., Corwin, J. T., and Jones, J. E. (1990). Regenerated hair cells can originate
from supporting cell progeny: evidence from phototoxicity and laser ablation
experiments in the lateral line system. J. Neurosci. 10, 2502–2512.
Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell
136, 215–233. doi: 10.1016/j.cell.2009.01.002
Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., et al.
(2003). Dicer is essential for mouse development. Nat. Genet. 35, 215–217. doi:
10.1038/ng1253
Carthew, R. W., and Sontheimer, E. J. (2009). Origins and mechanisms of miRNAs
and siRNAs. Cell 136, 642–655. doi: 10.1016/j.cell.2009.01.035
Ciofﬁ, J. A., Yue, W. Y., Mendolia-Loffredo, S., Hansen, K. R., Wackym, P. A., and
Hansen, M. R. (2010). MicroRNA-21 overexpression contributes to vestibular
schwannoma cell proliferation and survival. Otol. Neurotol. 31, 1455–1462. doi:
10.1097/MAO.0b013e3181f20655
Ciorba, A., Gasparini, P., Chicca,M., Pinamonti, S., andMartini, A. (2010). Reactive
oxygen species in human inner ear perilymph. Acta Otolaryngol. 130, 240–246.
doi: 10.3109/00016480903143978
Circu, M. L., and Aw, T. Y. (2010). Reactive oxygen species, cellular
redox systems, and apoptosis. Free Radic. Biol. Med. 48, 749–762. doi:
10.1016/j.freeradbiomed.2009.12.022
Da Sacco, L., Baldassarre, A., and Masotti, A. (2012). Bioinformatics tools and novel
challenges in long non-coding RNAs (lncRNAs) functional analysis. Int. J. Mol.
Sci. 13, 97–114. doi: 10.3390/ijms13010097
Elkan-Miller, T., Ulitsky, I., Hertzano, R., Rudnicki, A., Dror, A. A., Lenz, D. R.,
et al. (2011). Integration of transcriptomics, proteomics, andmicroRNA analyses
reveals novel microRNA regulation of targets in the mammalian inner ear. PLoS
ONE 6:e18195. doi: 10.1371/journal.pone.0018195
Friedland, D. R., Eernisse, R., Erbe, C., Gupta, N., and Ciofﬁ,
J. A. (2009). Cholesteatoma growth and proliferation: posttranscrip-
tional regulation by microRNA-21. Otol. Neurotol. 30, 998–1005. doi:
10.1097/MAO.0b013e3181b4e91f
Friedman, L. M., Dror, A. A., Mor, E., Tenne, T., Toren, G., Satoh, T., et al.
(2009). MicroRNAs are essential for development and function of inner ear
hair cells in vertebrates. Proc. Natl. Acad. Sci. U.S.A. 106, 7915–7920. doi:
10.1073/pnas.0812446106
Frucht, C. S., Santos-Sacchi, J., and Navaratnam, D. S. (2011). MicroRNA181a plays
a key role in hair cell regeneration in the avian auditory epithelium. Neurosci.
Lett. 493, 44–48. doi: 10.1016/j.neulet.2011.02.017
Frucht, C. S., Uduman, M., Duke, J. L., Kleinstein, S. H., Santos-Sacchi, J., and
Navaratnam, D. S. (2010). Gene expression analysis of forskolin treated basi-
lar papillae identiﬁes microRNA181a as a mediator of proliferation. PLoS ONE
5:e11502. doi: 10.1371/journal.pone.0011502
Gu, C., Li, X., Tan, Q., Wang, Z., Chen, L., and Liu, Y. (2013). MiR-183 family
regulates chloride intracellular channel 5 expression in inner ear hair cells.Toxicol.
In Vitro 27, 486–491. doi: 10.1016/j.tiv.2012.07.008
Guo, H., Ingolia, N. T., Weissman, J. S., and Bartel, D. P. (2010). Mammalian
microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–
840. doi: 10.1038/nature09267
Guttman, M., Amit, I., Garber, M., French, C., Lin, M. F., Feldser, D., et al.
(2009). Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature 458, 223–227. doi: 10.1038/nature
07672
Hertzano, R., Elkon, R., Kurima, K., Morrisson, A., Chan, S. L., Sallin, M., et al.
(2011). Cell type-speciﬁc transcriptome analysis reveals a major role for Zeb1
and miR-200b in mouse inner ear morphogenesis. PLoS Genet. 7:e1002309. doi:
10.1371/journal.pgen.1002309
Heuston, E. F., Lemon, K. T., and Arceci, R. J. (2011). The begin-
ning of the road for non-coding RNAs in normal hematopoiesis and
hematologic malignancies. Front. Genet. 2:94. doi: 10.3389/fgene.2011.
00094
Hildebrand, M. S., Witmer, P. D., Xu, S., Newton, S. S., Kahrizi, K., Najmabadi, H.,
et al. (2010). miRNA mutations are not a common cause of deafness. Am. J. Med.
Genet. A. 152A, 646–652. doi: 10.1002/ajmg.a.33299
Inukai, S., and Slack, F. (2013). MicroRNAs and the genetic network in aging. J. Mol.
Biol. 425, 3601–3608. doi: 10.1016/j.jmb.2013.01.023
Janssen, H. L., Reesink, H.W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel,
K., et al. (2013). Treatment of HCV infection by targeting microRNA. N. Engl. J.
Med. 368, 1685–1694. doi: 10.1056/NEJMoa1209026
Jin, Z. B., Hirokawa, G., Gui, L., Takahashi, R., Osakada, F., Hiura, Y., et al. (2009).
Targeted deletion of miR-182, an abundant retinal microRNA. Mol. Vis. 15,
523–533.
Karali, M., Peluso, I., Marigo, V., and Banﬁ, S. (2007). Identiﬁcation and characteri-
zation of microRNAs expressed in the mouse eye. Invest. Ophthalmol. Vis. Sci. 48,
509–515. doi: 10.1167/iovs.06-0866
Kelley, M.W. (2006). Regulation of cell fate in the sensory epithelia of the inner ear.
Nat. Rev. Neurosci. 7, 837–849. doi: 10.1038/nrn1987
Kersigo, J., D’angelo, A., Gray, B. D., Soukup, G. A., and Fritzsch, B. (2011). The
role of sensory organs and the forebrain for the development of the craniofacial
shape as revealed by Foxg1-cre-mediated microRNA loss. Genesis 49, 326–341.
doi: 10.1002/dvg.20714
Koehler, K. R., Mikosz, A. M., Molosh, A. I., Patel, D., and Hashino, E. (2013). Gen-
eration of inner ear sensory epithelia from pluripotent stem cells in 3D culture.
Nature 500, 217–221. doi: 10.1038/nature12298
Kopke, R., Allen, K. A., Henderson, D., Hoffer, M., Frenz, D., and Van De
Water, T. (1999). A radical demise. Toxins and trauma share common pathways
in hair cell death. Ann. N. Y. Acad. Sci. 884, 171–191. doi: 10.1111/j.1749-
6632.1999.tb08641.x
Kozomara, A., and Grifﬁths-Jones, S. (2011). miRBase: integrating microRNA
annotation and deep-sequencing data. Nucleic Acids Res. 39, D152–D157. doi:
10.1093/nar/gkq1027
Kuhn, S., Johnson, S. L., Furness, D. N., Chen, J., Ingham, N., Hilton, J. M.,
et al. (2011). miR-96 regulates the progression of differentiation in mammalian
cochlear inner and outer hair cells. Proc. Natl. Acad. Sci. U.S.A. 108, 2355–2360.
doi: 10.1073/pnas.1016646108
Lagos-Quintana,M., Rauhut, R., Lendeckel,W., and Tuschl, T. (2001). Identiﬁcation
of novel genes coding for small expressed RNAs. Science 294, 853–858. doi:
10.1126/science.1064921
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., and Tuschl, T.
(2002). Identiﬁcation of tissue-speciﬁc microRNAs from mouse. Curr. Biol. 12,
735–739. doi: 10.1016/S0960-9822(02)00809-6
Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005). Conserved seed pairing, often
ﬂanked by adenosines, indicates that thousands of human genes are microRNA
targets. Cell 120, 15–20. doi: 10.1016/j.cell.2004.12.035
Frontiers in Molecular Neuroscience www.frontiersin.org December 2013 | Volume 6 | Article 52 | 8
“fnmol-06-00052” — 2013/12/20 — 10:19 — page 9 — #9
Ushakov et al. MicroRNAs in sensorineural diseases of the ear
Lewis, M. A., Quint, E., Glazier, A. M., Fuchs, H., De Angelis, M. H., Langford, C.,
et al. (2009). An ENU-induced mutation of miR-96 associated with progressive
hearing loss in mice. Nat. Genet. 41, 614–618. doi: 10.1038/ng.369
Li, H., Kloosterman,W., and Fekete, D. M. (2010). MicroRNA-183 family members
regulate sensorineural fates in the inner ear. J. Neurosci. 30, 3254–3263. doi:
10.1523/JNEUROSCI.4948-09.2010
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A.,
Jackson, M. A., et al. (2013). The diagnosis and management of acute otitis
media. Pediatrics 131, e964–e999. doi: 10.1542/peds.2012-3488
Lindow, M., and Kauppinen, S. (2012). Discovering the ﬁrst microRNA-targeted
drug. J. Cell Biol. 199, 407–412. doi: 10.1083/jcb.201208082
Lumayag, S., Haldin, C. E., Corbett, N. J., Wahlin, K. J., Cowan, C., Turturro, S.,
et al. (2013). Inactivation of the microRNA-183/96/182 cluster results in syn-
dromic retinal degeneration. Proc. Natl. Acad. Sci. U.S.A. 110, E507–E516. doi:
10.1073/pnas.1212655110
Manji, S. S., Sorensen, B. S., Klockars, T., Lam, T., Hutchison, W., and Dahl, H. H.
(2006). Molecular characterization and expression of maternally expressed gene
3 (Meg3/Gtl2) RNA in the mouse inner ear. J. Neurosci. Res. 83, 181–190. doi:
10.1002/jnr.20721
Mencia, A., Modamio-Hoybjor, S., Redshaw, N., Morin, M., Mayo-Merino, F.,
Olavarrieta, L., et al. (2009). Mutations in the seed region of human miR-96 are
responsible for nonsyndromic progressive hearing loss. Nat. Genet. 41, 609–613.
doi: 10.1038/ng.355
Mustaﬁ, D., Kevany, B. M., Bai, X., Maeda, T., Sears, J. E., Khalil, A. M., et al. (2013).
Evolutionarily conserved long intergenic non-coding RNAs in the eye.Hum.Mol.
Genet. 22, 2992–3002. doi: 10.1093/hmg/ddt156
Oshlack, A., Robinson, M. D., and Young, M. D. (2010). From RNA-seq reads to
differential expression results. Genome Biol. 11, 220. doi: 10.1186/gb-2010-11-
12-220
Park, C. Y., Jeker, L. T., Carver-Moore, K., Oh, A., Liu, H. J., Cameron, R., et al.
(2012). A resource for the conditional ablation of microRNAs in the mouse. Cell
Rep. 1, 385–391. doi: 10.1016/j.celrep.2012.02.008
Patel, M., Cai, Q., Ding, D., Salvi, R., Hu, Z., and Hu, B. H. (2013). The miR-
183/Taok1 target pair is implicated in cochlear responses to acoustic trauma.
PLoS ONE 8:e58471. doi: 10.1371/journal.pone.0058471
Pers, Y. M., and Jorgensen, C. (2013). MicroRNA in 2012: biotherapeutic poten-
tial of microRNAs in rheumatic diseases. Nat. Rev. Rheumatol. 9, 76–78. doi:
10.1038/nrrheum.2012.236
Piva, R., Spandidos, D. A., and Gambari, R. (2013). From microRNA functions to
microRNA therapeutics: novel targets and novel drugs in breast cancer research
and treatment. Int. J. Oncol. 43, 985–994.
Ponting, C. P., Oliver, P. L., and Reik, W. (2009). Evolution and functions of long
noncoding RNAs. Cell 136, 629–641. doi: 10.1016/j.cell.2009.02.006
Roberts, K. A., Abraira, V. E., Tucker, A. F., Goodrich, L. V., and Andrews, N.
C. (2012). Mutation of Rubie, a novel long non-coding RNA located upstream
of Bmp4, causes vestibular malformation in mice. PLoS ONE 7:e29495. doi:
10.1371/journal.pone.0029495
Rosengauer, E., Hartwich, H., Hartmann, A. M., Rudnicki, A., Satheesh, S. V.,
Avraham, K. B., et al. (2012). Egr2::cre mediated conditional ablation of dicer
disrupts histogenesis of mammalian central auditory nuclei. PLoSONE 7:e49503.
doi: 10.1371/journal.pone.0049503
Sacheli, R., Nguyen, L., Borgs, L., Vandenbosch, R., Bodson, M., Lefebvre, P., et al.
(2009). Expression patterns of miR-96,miR-182 andmiR-183 in the development
inner ear. Gene Expr. Patterns 9, 364–370. doi: 10.1016/j.gep.2009.01.003
Solda, G., Robusto, M., Primignani, P., Castorina, P., Benzoni, E., Cesarani, A., et al.
(2012). A novelmutationwithin theMIR96 gene causes non-syndromic inherited
hearing loss in an Italian family by altering pre-miRNA processing. Hum. Mol.
Genet. 21, 577–585. doi: 10.1093/hmg/ddr493
Song, J. J., Kwon, S. K., Cho, C. G., Park, S. W., and Chae, S. W. (2011). Microarray
analysis of microRNA expression in LPS induced inﬂammation of humanmiddle
ear epithelial cells (HMEECs). Int. J. Pediatr. Otorhinolaryngol. 75, 648–651. doi:
10.1016/j.ijporl.2011.02.001
Soukup, G. A., Fritzsch, B., Pierce, M. L., Weston, M. D., Jahan, I., Mcmanus, M.
T., et al. (2009). Residual microRNA expression dictates the extent of inner ear
development in conditional Dicer knockout mice. Dev. Biol. 328, 328–341. doi:
10.1016/j.ydbio.2009.01.037
Stone, J. S., and Cotanche, D. A. (2007). Hair cell regeneration in the avian auditory
epithelium. Int. J. Dev. Biol. 51, 633–647. doi: 10.1387/ijdb.072408js
Tsonis, P. A., Call, M. K., Grogg, M. W., Sartor, M. A., Taylor, R. R., Forge, A.,
et al. (2007). MicroRNAs and regeneration: let-7 members as potential regula-
tors of dedifferentiation in lens and inner ear hair cell regeneration of the adult
newt. Biochem. Biophys. Res. Commun. 362, 940–945. doi: 10.1016/j.bbrc.2007.
08.077
Ulitsky, I., andBartel,D. P. (2013). lincRNAs: genomics, evolution, andmechanisms.
Cell 154, 26–46. doi: 10.1016/j.cell.2013.06.020
Wang, X. R., Zhang, X. M., Du, J., and Jiang, H. (2012). MicroRNA-182 regulates
otocyst-derived cell differentiation and targets T-box1 gene.Hear. Res. 286, 55–63.
doi: 10.1016/j.heares.2012.02.005
Wang, X. R., Zhang, X. M., Zhen, J., Zhang, P. X., Xu, G., and Jiang, H. (2010a).
MicroRNA expression in the embryonic mouse inner ear. Neuroreport 21, 611–
617. doi: 10.1097/WNR.0b013e328338864b
Wang, Z., Liu, Y., Han, N., Chen, X., Yu, W., Zhang, W., et al. (2010b). Proﬁles of
oxidative stress-related microRNA and mRNA expression in auditory cells. Brain
Res. 1346, 14–25. doi: 10.1016/j.brainres.2010.05.059
Weston, M. D., Pierce, M. L., Jensen-Smith, H. C., Fritzsch, B., Rocha-Sanchez, S.,
Beisel, K. W., et al. (2011). MicroRNA-183 family expression in hair cell devel-
opment and requirement of microRNAs for hair cell maintenance and survival.
Dev. Dyn. 240, 808–819. doi: 10.1002/dvdy.22591
Weston, M. D., Pierce, M. L., Rocha-Sanchez, S., Beisel, K. W., and Soukup, G.
A. (2006). MicroRNA gene expression in the mouse inner ear. Brain Res. 1111,
95–104. doi: 10.1016/j.brainres.2006.07.006
Wienholds, E., Kloosterman, W. P., Miska, E., Alvarez-Saavedra, E., Berezikov,
E., De Bruijn, E., et al. (2005). MicroRNA expression in zebraﬁsh embryonic
development. Science 309, 310–311. doi: 10.1126/science.1114519
Yan, D., Xing, Y., Ouyang, X., Zhu, J., Chen, Z. Y., Lang, H., et al. (2012). Analysis
of miR-376 RNA cluster members in the mouse inner ear. Int. J. Exp. Pathol. 93,
450–457. doi: 10.1111/j.1365-2613.2012.00840.x
Young, T. L., Matsuda, T., and Cepko, C. L. (2005). The noncoding RNA taurine
upregulated gene 1 is required for differentiation of the murine retina. Curr. Biol.
15, 501–512. doi: 10.1016/j.cub.2005.02.027
Yu, L., Tang, H., Jiang, X. H., Tsang, L. L., Chung, Y. W., and Chan, H. C. (2010).
Involvement of calpain-I and microRNA34 in kanamycin-induced apoptosis of
inner ear cells. Cell Biol. Int. 34, 1219–1225. doi: 10.1042/CBI20100515
Zhang, Q., Liu, H., Mcgee, J., Walsh, E.J., Soukup, G.A., and He, D.Z. (2013).
Identifying microRNAs involved in degeneration of the organ of corti dur-
ing age-related hearing loss. PLoS ONE 8:e62786. doi: 10.1371/journal.pone.
0062786
Conflict of Interest Statement:The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 19 September 2013; paper pending published: 17 October 2013; accepted: 04
December 2013; published online: 23 December 2013.
Citation: Ushakov K, Rudnicki A andAvrahamKB (2013)MicroRNAs in sensorineural
diseases of the ear. Front. Mol. Neurosci. 6:52. doi: 10.3389/fnmol.2013.00052
This article was submitted to the journal Frontiers in Molecular Neuroscience.
Copyright © 2013 Ushakov, Rudnicki and Avraham. This is an open-access arti-
cle distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original pub-
lication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Molecular Neuroscience www.frontiersin.org December 2013 | Volume 6 | Article 52 | 9
